Drug Development Consultant and Regulatory Consultant

Comments (0)

Apple Puts Onus of FDA Clearance on iPhone Developers

As more and more developers are make applications (apps) for the Apple iPhone, using at as in interface for medical devices is an obviouse solution and one that make alot of commercial sence

Comments (0)

Twitter Weekly Updates for 2009-06-28

Drug development planning is a clear process starting at your desired goal and working back from there! #
The access to finance programme running in Yorkshire is looking out for participants! Get investor ready! #
My website is now ranked top 3 on google! Which is nice! Google has recognised the huge amount of high quality content! [...]

Comments (0)

Drug Patent Settlements Cost Consumers US$3.5bn annualy in the USA

a ban on patent settlements between brand and generic drugmakers would reduce spending on prescription drugs by $3.5 billion each year

Comments (0)

Non GMP stock allowable for Human Radiolabled PK studies

Since 2004, there has been a clear requirement to manufacture the IP (drug product) to Good Manufacturing Practice (GMP), however the quality standard required for the radiolabelled Active Pharmaceutical Ingredient (API) was open to interpretation.

Comments (1)

Drugmakers reach deal to reduce US Medicare coverage gap

The pharmaceutical industry agreed to a proposal to provide drug discounts to US Medicare beneficiaries that could be worth up to $80 billion over the next ten years.

Comments (0)

MHRA guidance on the vigilance systems for medical devices- Intraocular lenses

This guidance document gives advice to manufacturers on the notification of adverse incidents involving intra-ocular lenses under medical devices the chilling system. It includes, but is not limited to, the following types of intraocular lenses: posterior chamber; phakic; anterior chamber; multifocal; and accommodated. It is intended to facilitate uniform application implementation of the medical devices directive.

Comments (0)

Twitter Weekly Updates for 2009-06-21

Putting course materials together for the 100% programme! 100% funding! 100% of the time! #
Giving something back is a pleasure and an obligation Sign up for the science and technology ambassador programme Inspire the next gen! #
Framework 7 is looking like a great opportunity for fund raising especially the ideas fund. I personaly am going [...]

Comments (0)

Guidline on Quality, Non-Clinical and Clinical Aspects of Live Recombinant Viral Vectored Vaccines

EMEA publishes new guidlines, “Guidline on Quality, Non-Clinical and Clinical Aspects of Live Recombinant Viral Vectored Vaccines”

Comments (3)

Guest Article – The Fight Against Influenza

The recent Swine Flu scare caused a hubbub among the health world in the past few months as many health officials and scientists scrambled to find a cure for this new pandemic disease that was sweeping the world.

Comments (0)

Customer Testemonial

“We valued the input from IDA consultants, their commercial and scientific mix was especially helpful with the planning process”

Dr Suzanne Emmett - YTKO